Cargando…
Deferoxamine mesylate improves splicing and GAA activity of the common c.-32-13T>G allele in late-onset PD patient fibroblasts
Pompe disease (PD) is an autosomal recessive lysosomal storage disorder due to deficient activity of the acid alpha glucosidase enzyme (GAA). As a consequence of the enzymatic defect, undigested glycogen accumulates within lysosomes. Most patients affected by the late-onset (LO) phenotype carry in a...
Autores principales: | Buratti, Emanuele, Peruzzo, Paolo, Braga, Luca, Zanin, Irene, Stuani, Cristiana, Goina, Elisa, Romano, Maurizio, Giacca, Mauro, Dardis, Andrea |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Gene & Cell Therapy
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7782201/ https://www.ncbi.nlm.nih.gov/pubmed/33426149 http://dx.doi.org/10.1016/j.omtm.2020.11.011 |
Ejemplares similares
-
Functional characterization of the common c.-32-13T>G mutation of GAA gene: identification of potential therapeutic agents
por: Dardis, Andrea, et al.
Publicado: (2014) -
Glycogen Reduction in Myotubes of Late-Onset Pompe Disease Patients Using Antisense Technology
por: Goina, Elisa, et al.
Publicado: (2017) -
The Clinical Effect of Deferoxamine Mesylate on Edema after Intracerebral Hemorrhage
por: Yu, Yao, et al.
Publicado: (2015) -
SR protein-mediated inhibition of CFTR exon 9 inclusion: molecular characterization of the intronic splicing silencer
por: Buratti, Emanuele, et al.
Publicado: (2007) -
Impact, Characterization, and Rescue of Pre-mRNA Splicing Mutations in Lysosomal Storage Disorders
por: Dardis, Andrea, et al.
Publicado: (2018)